Jae-Ho Cheong

27PUBLICATIONS
152CO-AUTHORS
BiomaterialsMolecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 28, 2026
Serum albumin maintains Wnt3a water solubility and activity.

|Sep 29, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.

Alessandra Raimondi, Gabriele Tinè, Alexej Ballhausen

|Mar 07, 2025
SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancreatic cancer cells.

Minsoo Kim, Woosol Chris Hong, Hyeon Woong Kang

|Jul 12, 2024
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.

Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook

|May 30, 2024
Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication.

Pasqualino de Antonellis, Veronica Ferrucci, Marco Miceli

|May 08, 2024
Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.

Yoon Young Choi, Myeongjee Lee, Eun Hwa Kim

Pageof 5

Frequent Collaborators

9 joint publications

Sung Hoon Noh

8 joint publications

Youn Young Choi

8 joint publications

Hyoung-Il Kim

8 joint publications

Woo Jin Hyung